Embecta (EMBC) Total Current Liabilities (2021 - 2026)
Embecta (EMBC) reported Total Current Liabilities of $247.3 million for Q1 2026, down 4.63% on a YoY basis from $259.3 million in Q1 2025, and up 5.37% sequentially from $234.7 million in Q4 2025.
Embecta (EMBC) Total Current Liabilities (2021 - 2026) Analysis & Trends
Embecta (EMBC) has 6 years of Total Current Liabilities data on file, last reported at $247.3 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities fell 4.63% year-over-year to $247.3 million; the trailing twelve-month figure through Mar 2026 stood at $247.3 million (down 4.63% YoY), and the FY2025 full-year result was $261.5 million, down 30.08% from the prior year.
- Total Current Liabilities grew to $247.3 million in Q1 2026, from $234.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $385.8 million in Q2 2023 to a low of $168.9 million in Q1 2022.
- A 5-year average of $301.4 million and a median of $301.0 million in 2022 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities surged 132.75% in 2022 and plunged 30.08% in 2025, its largest moves.
- Tracing EMBC's Total Current Liabilities over 5 years: stood at $370.3 million in 2022, then decreased by 11.8% to $326.6 million in 2023, then slipped by 8.7% to $298.2 million in 2024, then slipped by 21.29% to $234.7 million in 2025, then grew by 5.37% to $247.3 million in 2026.
- Business Quant data shows EMBC's Total Current Liabilities at $247.3 million in Q1 2026, $234.7 million in Q4 2025, and $261.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | 247.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 247.30 Mn |
| Dec 31, 2025 | 234.70 Mn |
| Sep 30, 2025 | 261.50 Mn |
| Jun 30, 2025 | 275.50 Mn |
| Mar 31, 2025 | 259.30 Mn |
| Dec 31, 2024 | 298.20 Mn |
| Sep 30, 2024 | 374.00 Mn |
| Jun 30, 2024 | 370.70 Mn |
| Mar 31, 2024 | 310.40 Mn |
| Dec 31, 2023 | 326.60 Mn |
| Sep 30, 2023 | 353.50 Mn |
| Jun 30, 2023 | 385.80 Mn |
| Mar 31, 2023 | 357.70 Mn |
| Dec 31, 2022 | 370.30 Mn |
| Sep 30, 2022 | 301.00 Mn |
| Jun 30, 2022 | 228.50 Mn |
| Mar 31, 2022 | 168.90 Mn |
| Dec 31, 2021 | 159.10 Mn |
| Sep 30, 2021 | 164.00 Mn |